BioStrand (a subsidiary of IPA)’s Post

Montai CSO Lamya Shihabuddin is chairing the #PDDPSummit today in Boston. Together with leaders from across the drug discovery landscape, Lamya is sharing insights on how Montai is leveraging AI to create more precision and predictability in early #drugdiscovery. 

Learn how AI is revolutionizing drug discovery. Discover how Valo Health and Charles River Laboratories are infusing AI and human-centric data into the process to find innovative drug candidates faster and more efficiently. Read more in this Nature article. https://okt.to/XU6hFI

At last week's #TechBioUK the BioIndustry Association (BIA) launched its 'TechBio: UK leads innovation frontier' report in collaboration with Citeline. The report delves into the latest advancements driven by AI and data-driven approaches, which are revolutionising drug discovery, diagnostics and personalised medicine. Access it here - https://ow.ly/YJOy50TNsoF #AI #Data #DrugDiscovery

Learn how AI is revolutionizing drug discovery. Discover how Valo Health and Charles River Laboratories are infusing AI and human-centric data into the process to find innovative drug candidates faster and more efficiently. Read more in this Nature article. https://okt.to/vCDyde

Missed our webinar on how to successfully implement AI in drug discovery with panel insights from John Overington, Darren Green and Matthew Segall? No worries - you can catch up whenever you like with our recording! https://lnkd.in/dG9PwRFB #ArtificialIntelligence #MachineLearning #DrugDiscovery

If you're at #SDDS (Stanford Drug Discovery Symposium) today or tomorrow and want to chat about the Spring Science AI/ML platform, let me know! #drugdiscovery

Below is a great article discussing how #logica can accelerate a client's drug discovery pipeline by deploying a combination of AI/ML and wet science approaches. #ai #aidrugdiscovery

We are pleased to share that a new article, “Generative AI Finds Its Footing in Drug Development,” has been published on BioSpace. In this piece, Bryan Hill, VP and Chief Digital Officer for Life Sciences at Cognizant, provides valuable insights about how biopharma companies are moving beyond a theoretical understanding of generative AI and embracing practical applications. #LifeSciences #GenAI #GenerativeAI

Dive into the future of healthcare with our latest white paper on #GenerativeAI Implementation in #LifeSciences. Learn how #AI is revolutionizing drug discovery, patient care and more. Download now and stay ahead of the curve. https://ow.ly/GrsZ50QQnWq Tanuj Mehra, Erion Lipo, Ph.D., Kevin Yin, Jordan A. S.

AI for target discovery: the start of a long road. In the fifth and final article in BioCentury's Back to School 2024, Editor in Chief Simone Fishburn and colleague write that investments in AI in drug discovery are picking up, as the picture starts to form of how target discovery may benefit